📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

PCSK9 inhibition and type 2 diabetes (2017)

First Author: Lotta L

Attributed to: Epidemiological contribution to primary and secondary prevention of diabetes and obesity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(17)30321-2

PubMed Identifier: 28927707

Publication URI: http://europepmc.org/abstract/MED/28927707

Type: Journal Article/Review

Parent Publication: The Lancet Diabetes & Endocrinology

Issue: 12

ISSN: 2213-8587